Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma

Leuk Res. 2005 Oct;29(10):1233-4. doi: 10.1016/j.leukres.2005.03.003. Epub 2005 Apr 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Drug Resistance, Neoplasm*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Salvage Therapy
  • Topotecan / administration & dosage
  • Treatment Failure

Substances

  • Topotecan
  • Cyclophosphamide